Quick answer
Reishi has one early finding, a rise in some immune cell counts with a purified beta-glucan at 200 mg a day. Chaga has no trial in people and no studied amount. Both are woody tree fungi, and the harm reported for each involved powders: kidney damage for chaga, rare liver injury for reishi.1,2,3
Key facts
- LiverTox gives reishi's usual amount as 500 mg to 3 g a day. No daily amount has been set for chaga.2,3
- A 2025 review pooled 17 randomized trials of reishi in 971 people and rated the certainty of every finding very low.4
- Chaga extracts from Finland, Russia and Thailand all had oxalic acid as their main organic acid. Reishi is known for polysaccharides and bitter triterpenes.2,5
- Reishi's ganoderic acids appeared in the blood within 5 to 10 minutes of a 3 g dose and halved in under 40 minutes. We found no such measurement for chaga.6
Chaga and reishi, line by line
| Chaga | Reishi | |
|---|---|---|
| Other names | Inonotus obliquus, chaga mushroom | Lingzhi, Ganoderma lucidum, Ganoderma lingzhi, red reishi |
| Where it grows | As a parasite on birch and other trees | At the base of trees and on stumps; farmed on logs, sawdust or wood chips |
| Compounds named in the research | Oxalic acid as the main organic acid; polysaccharides, phenolic compounds and peptides in laboratory studies | Polysaccharides, mostly beta-glucans, and bitter triterpenes called ganoderic acids |
| Human evidence | None of chaga alone | 17 randomized trials pooled in 2025, certainty very low |
| Amounts | None studied | 500 mg to 3 g a day is the usual range; trials used 200 mg to 11.2 g |
| What happens to a dose | Not measured in the sources we read | Ganoderic acids reach the blood in minutes and halve in under 40 minutes |
| What has been reported | Oxalate kidney damage after daily powder | Rare liver injury, usually 1 to 2 months after starting |
What each one contains
Reishi contains polysaccharides, triterpenoids, sterols, fatty acids, proteins and trace elements. Which of them, if any, act in the body is unknown.2
Water and alcohol extracts of chaga from Finland, Russia and Thailand all contained oxalic acid as their main organic acid, the most in a Russian water extract.5
The two chemistries point in different directions. Reishi's compounds are the ones its research is organized around, and no one knows which of them, if any, act in the body. Chaga's best documented chemical fact is its oxalate, which has been linked to harm rather than to anything graded as a benefit.2,3
What has been shown in people
Reishi has one graded finding, and it belongs to a purified extract rather than to the whole mushroom.
A purified reishi beta-glucan may raise counts of some immune cells in healthy adults*1,8,9,10
Early evidence
In a randomized, placebo-controlled trial in healthy adults aged 18 to 55 (157 enrolled, 135 finished), 200 mg a day of a purified reishi beta-glucan for 12 weeks raised counts of several kinds of T cells and natural killer cells more than placebo. It did not measure whether people fell ill less often, and a company paid for it. A trial in young children who ate a yogurt with reishi beta-glucans found a similar rise. Whole reishi did not show this: 1.44 g a day for 4 weeks, and 4 g a day of an extract for 10 days, left immune measures unchanged in small trials.
Amount studied: 200 mg a day of purified reishi beta-glucan, for 12 weeks
A 2025 pooled analysis of 17 randomized trials in 971 people rated the certainty of every reishi finding as very low.4
For chaga there is nothing to grade. The only human work we found was a one-time trial of an herb mixture and a laboratory test on blood cells, and neither gave chaga alone to people over time.11,12
Amounts and what happens to a dose
Trials in healthy adults gave 0.72 to 4 g a day of whole reishi preparations or extracts, for 10 days to 4 weeks.9,10,13,14
A 2025 review of 17 randomized trials found daily amounts from 200 mg to 11.2 g, taken for 1 to 24 weeks.4
Chaga offers no matching list. In the chaga sources we read, the only amounts in grams come from case reports of people who had kidney damage, at 3 to 15 g of powder a day for 3 months to 5 years. Those are descriptions of harm, not amounts anyone set out to test.3,7
Powders, extracts and purified fractions
Reishi is sold as an extract on its own or in blends with other herbs, and as powders, dried slices and spore powder.2
A purified reishi beta-glucan concentrates one group of compounds. The rise in immune cells seen with it did not appear in small trials of whole reishi at 1.44 to 4 g a day.1,9,10
Chaga is sold as a ground powder, and every published case of kidney damage involved chaga powder taken daily.3,7,15
A shared pattern is worth noting. In both mushrooms the reported harm clustered around powders. Two of the reishi liver cases began after a switch to a powdered product, and all the chaga kidney cases involved daily powder.2,7
What's in ours
Our Mushroom Complex gives reishi its own row, 266 mg of extract from the fruiting body with no beta-glucan figure, so it cannot be matched to the 200 mg purified beta-glucan in the trial. Chaga sits inside a shared blend row with five other mushrooms. We make no claim for either in it.1
Kidney, liver and who should ask first
Oxalate nephropathy, kidney damage from oxalate crystals, has been reported in at least three people who took chaga powder every day for months or years.3,7,15
A 49-year-old man who took 3 g of chaga powder a day for four years, then 9 g a day for a year, developed kidney failure and was still on dialysis 18 months later.3
Rare cases of liver injury have been reported, usually 1 to 2 months after starting reishi, with tiredness, nausea, stomach pain, poor appetite, dark urine or yellowing of the skin and eyes. Most people recovered within 1 to 3 months of stopping, but one woman died.2
In trials of 1.4 to 3 g a day for 12 to 16 weeks in adults with type 2 diabetes, side effects were reported somewhat more often with reishi than with placebo, a difference that may be due to chance. None was serious.16
- Do not take chaga if you have kidney disease or have had kidney stones, unless your kidney doctor agrees3
- Do not take reishi if you have had a liver reaction to it before, and ask first if you have liver disease2
- Ask first about either if you take a blood thinner or antiplatelet medicine, or have surgery planned17,18
- Ask first about either if you take medicine for blood sugar: laboratory and animal studies point that way for both2,19
- Ask first about reishi if you take medicines that suppress the immune system, or if you are allergic to mushrooms or molds1
- Ask first if you are being treated for cancer, or are pregnant or breastfeeding
Questions people ask
What is the difference between chaga and reishi?
Chaga is a fungus that lives on birch and other trees and is known chemically for oxalic acid. Reishi, or lingzhi, grows at the base of trees and on stumps, and is known for polysaccharides and bitter triterpenes. Reishi has one early graded finding. Chaga has none.1,2,5,7
See what we make
Every product shows its whole label and what its lab report covers. The store opens soon.
Sources
- Chen SN, Nan FH, Liu MW, Yang MF, Chang YC, Chen S. Evaluation of Immune Modulation by β-1,3; 1,6 D-Glucan Derived from Ganoderma lucidum in Healthy Adult Volunteers, A Randomized Controlled Trial. Foods. 2023;12(3):659. Opened 2026-10-07.
- LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Lingzhi, Reishi. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases. Last update October 5, 2024. Opened 2026-10-07.
- Lee S, Lee HY, Park Y, Ko EJ, Ban TH, Chung BH, Lee HS, Yang CW. Development of End Stage Renal Disease after Long-Term Ingestion of Chaga Mushroom: Case Report and Review of Literature. J Korean Med Sci. 2020;35(19):e122. Opened 2026-10-07.
- Jafari A, Mardani H, Mirzaei Fashtali Z, Arghavan B. The Nutritional Significance of Ganoderma lucidum on Human Health: A GRADE-Assessed Systematic Review and Meta-Analysis of Clinical Trials. Food Sci Nutr. 2025;13(6):e70423. Opened 2026-10-07.
- Glamočlija J, Ćirić A, Nikolić M, Fernandes Â, Barros L, Calhelha RC, Ferreira IC, Soković M, van Griensven LJ. Chemical characterization and biological activity of Chaga (Inonotus obliquus), a medicinal "mushroom". J Ethnopharmacol. 2015;162:323-332. Opened 2026-10-07.
- Teekachunhatean S, Sadja S, Ampasavate C, Chiranthanut N, Rojanasthien N, Sangdee C. Pharmacokinetics of ganoderic acids A and F after oral administration of Ling Zhi preparation in healthy male volunteers. Evid Based Complement Alternat Med. 2012;2012:780892. Opened 2026-10-07.
- Kwon O, Kim Y, Paek JH, Park WY, Han S, Sin H, Jin K. Chaga mushroom-induced oxalate nephropathy that clinically manifested as nephrotic syndrome: A case report. Medicine (Baltimore). 2022;101(10):e28997. Opened 2026-10-07.
- Henao SLD, Urrego SA, Cano AM, Higuita EA. Randomized Clinical Trial for the Evaluation of Immune Modulation by Yogurt Enriched with β-Glucans from Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes), in Children from Medellin, Colombia. Int J Med Mushrooms. 2018;20(8):705-716. Opened 2026-10-07.
- Wachtel-Galor S, Tomlinson B, Benzie IF. Ganoderma lucidum ("Lingzhi"), a Chinese medicinal mushroom: biomarker responses in a controlled human supplementation study. Br J Nutr. 2004;91(2):263-269. Opened 2026-10-07.
- Wicks SM, Tong R, Wang CZ, O'Connor M, Karrison T, Li S, Moss J, Yuan CS. Safety and tolerability of Ganoderma lucidum in healthy subjects: a double-blind randomized placebo-controlled trial. Am J Chin Med. 2007;35(3):407-414. Opened 2026-10-07.
- Hong YH. Effects of the herb mixture, DTS20, on oxidative stress and plasma alcoholic metabolites after alcohol consumption in healthy young men. Integr Med Res. 2016;5(4):309-316. Opened 2026-10-07.
- Najafzadeh M, Reynolds PD, Baumgartner A, Jerwood D, Anderson D. Chaga mushroom extract inhibits oxidative DNA damage in lymphocytes of patients with inflammatory bowel disease. Biofactors. 2007;31(3-4):191-200. Opened 2026-10-07.
- Wachtel-Galor S, Szeto YT, Tomlinson B, Benzie IF. Ganoderma lucidum ('Lingzhi'); acute and short-term biomarker response to supplementation. Int J Food Sci Nutr. 2004;55(1):75-83. Opened 2026-10-07.
- Kwok Y, Ng KFJ, Li CCF, Lam CCK, Man RYK. A prospective, randomized, double-blind, placebo-controlled study of the platelet and global hemostatic effects of Ganoderma lucidum (Ling-Zhi) in healthy volunteers. Anesth Analg. 2005;101(2):423-426. Opened 2026-10-07.
- Kikuchi Y, Seta K, Ogawa Y, Takayama T, Nagata M, Taguchi T, Yahata K. Chaga mushroom-induced oxalate nephropathy. Clin Nephrol. 2014;81(6):440-444. Opened 2026-10-07.
- Klupp NL, Chang D, Hawke F, Kiat H, Cao H, Grant SJ, Bensoussan A. Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors. Cochrane Database Syst Rev. 2015;(2):CD007259. Opened 2026-10-07.
- Hyun KW, Jeong SC, Lee DH, Park JS, Lee JS. Isolation and characterization of a novel platelet aggregation inhibitory peptide from the medicinal mushroom, Inonotus obliquus. Peptides. 2006;27(6):1173-1178. Opened 2026-10-07.
- Warfarin sodium tablets: prescribing information (A-S Medication Solutions). DailyMed, U.S. National Library of Medicine. Published September 23, 2026. Opened 2026-10-07.
- Wang J, Wang C, Li S, Li W, Yuan G, Pan Y, Chen H. Anti-diabetic effects of Inonotus obliquus polysaccharides in streptozotocin-induced type 2 diabetic mice and potential mechanism via PI3K-Akt signal pathway. Biomed Pharmacother. 2017;95:1669-1677. Opened 2026-10-07.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
This page is information, not medical advice. Talk to your doctor or pharmacist about your own situation.